Kymera Therapeutics (KYMR) Other financing activities (2019 - 2026)
Kymera Therapeutics' Other financing activities came in at $436,000 for Q2 2026, up 14.1% from $382,000 a year earlier and up 2.6% from the prior quarter.
Kymera Therapeutics (KYMR) Other financing activities (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kymera Therapeutics reported Other financing activities of $1.7 million, up 6.5% year-over-year; for FY2025, it came in at $1.49 million, down 5.2% from FY2024.
- Other financing activities carries a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- Going back by year, Other financing activities was $1.58 million in FY2024, $76,000 in FY2023 (-93.3%), $1.13 million in FY2022 (+33.1%) and $849,000 in FY2021 (+53.2%).
- The Q2 2026 figure represents the highest quarterly Other financing activities since Q3 2024.
- Year-over-year, Other financing activities has increased for three consecutive quarters, with growth averaging 23.9% over the last seven quarters.
- The fastest year-over-year change in Other financing activities over five years came in Q3 2021 (growth of 222.9%), and the weakest in Q3 2025 (a decline of 34.6%).
- Business Quant data shows KYMR's Other financing activities at $425,000 (Q1 2026), $416,000 (Q4 2025) and $419,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 436,000.00 |
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 416,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 382,000.00 |
| Mar 31, 2025 | 277,000.00 |
| Dec 31, 2024 | 293,000.00 |
| Sep 30, 2024 | 641,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | -925,000.00 |
| Sep 30, 2023 | 340,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Mar 31, 2023 | 327,000.00 |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 292,000.00 |
| Jun 30, 2022 | 269,000.00 |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 156,000.00 |
| Sep 30, 2021 | 352,000.00 |
Kymera Therapeutics Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KYMR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();